User blogs

The so-called sex pill for women does not crack any medical taboos, but rather runs a very familiar route in Big Pharma's playbook - deceptive manipulation of clinical trial data.  What was different this time, from the other two when the FDA panel rejected Flibanserin, is that Sprout Pharmaceuticals ran a very effective "Even the Score" campaign making gender equality, not medical science, the issue.  Big Pharma, with the help of Madison Avenue, successfully diverted our attention away from what really matters when approving or denying any drug - whether the drug is effective and whether it is safe.

Even panelists who voted to approve the drug this time under public pressure did so reluctantly, expressing concerns about the drug's marginal benefits as demonstrated by the clinical trial data.

In one study, there were 135 clinical trial dropouts on Flibanserin versus only 101 dropouts on placebo. Likewise, in another clinical trial, there were 95 dropouts on 50mg Flibanserin, 114 dropouts on 100mg Flibanserin, versus only 75 dropouts on placebo.

The side effects of the drug caused more subjects taking the drug to drop out of the trials when compared to placebo.  In one study, 53 withdrew due to adverse effects of Flibanserin versus only 20 on placebo.

In typical Pharma fashion, those who dropped out of the clinical trials due to adverse effects did not get tallied in the final results, having the double effect of exaggerating the benefits of the drug while understating its risks.  It would be akin to our public schools boasting that students' test averages have improved, because more students flunked out of school, raising the average of the remaining students.

Even with the skewed clinical trial data, Flibanserin only led women on the drug to have sex one more time per month over women on placebo.  With such meager, albeit exaggerated benefits, to compare Flibanserin with Viagra is to deceive the public.  Viagra actually works.

We are witnessing Pharma's new wave of demographically targeted marketing.  It works, because co-opting existing, often worthy social agendas produces an instant "grassroots" movement.  The clever marketing strategy works just as well in the bedroom as it does in the classroom. Racial equality, for example, has been successfully co-opted by Big Pharma to unnecessarily drug an alarmingly increasing percentage of minority children for "mental disorders" like ADHD, under the banner that they have previously been denied equal access to mental health care.

If gender equality is the crux of the issue regarding Flibanserin, then the disproportionate reaction to a drug with such doubtful benefits shows us that women can be deceived by Big Pharma just as easily as men.
Piecing Together Polypharmacy Regimen of Mass Shooter Despite Heavy Report Redaction

On January 23, 2015, the Army released its long anticipated report on the second fatal mass shootings at Fort Hood that occurred on April 2, 2014. In support of the report, the Army simultaneously released five appendices contained in nineteen other files pertaining to Specialist Ivan Lopez's deadly shooting rampage.

In its findings, the Army concluded, "There was no evidence that any medication, or combination of medications, caused suicidal and/or homicidal thoughts in SPC Lopez-Lopez."  The Army continued: "There was no evidence that SPC Lopez-Lopez’s polypharmacy positive status would have triggered a high-risk flagging..."

In a very literal sense, there was no evidence contained in the report that any medication or combination of medications, known as polypharmacy, caused suicidal or homicidal ideation in Spc Lopez - because the Army made sure of it, seemingly redacting from its report every shred of evidence that could possibly point to such a conclusion.  Or did they?

Names of prescribed medications are obscured in the section of the report discussing Spc Lopez's behavioral health, with entire paragraphs blacked out.  As with Spc Lopez's medication history, the Army did not want to reveal which medications showed up in Spc Lopez's toxicology results.  Rather than stating that there were no medications present in Spc Lopez's post-mortem, the Army stated that the presence of medications was not abnormal, ie. expected and at therapeutic levels: "The autopsy results did not reveal any illegal drugs or the abnormal presence of any other medications in SPC Lopez-Lopez's blood."

In addition to large portions of the report and accompanying appendices being blacked out, notably missing from the redacted evidence was the entire Exhibits Tab "H" of Appendix 4, relating to Spc Ivan Lopez's psychiatric diagnosis, mental health treatment, and prescribed medications.

Undoubtedly, Exhibits Tab "H" contains evidence related to Spc Lopez's prescribed medications, since Exhibit H-14 is referred to in a footnote as "Lopez-Lopez Prescriptions (Recent to Oldest)."

Likewise, Exhibit H-11 is referred to in a footnote as "Lopez-Lopez Polypharmacy Timeline."

From comments by Lt. Gen. Mark Milley in a press conference shortly after the shootings, we know that Spc Lopez had been diagnosed with depression and anxiety, and had been prescribed and was taking Selective Serotonin Reuptake Inhibitor (SSRI) antidepressants.  Given Lt. Gen. Milley's loose lips in the immediate aftermath of the tragedy, it is unclear why the Army would then go to such lengths to conceal - from the families of the fallen, the survivors, our brave military personnel, and the American public - which, what combination of, and what doses of psychotropic medications Ivan Lopez was taking leading up to and at the time of his shooting rampage.

Regardless of the Army's motivation for going to such lengths to hide information that people living in a free country have a right to know, one conclusion is unavoidable: the Army was not exhaustive enough in its efforts to suppress the facts behind the second Fort Hood shootings.

From footnotes in the report and a supporting appendix, concerned parents intent on unveiling the hidden temporal link between psychotropics and mass shootings in America have pieced together the polypharmacy regimen prescribed to Spc Ivan Lopez.

Army records indicate that Spc Lopez was prescribed the following four psychotropic medications: Celexa (citralopram hydrobromide), Wellbutrin (bupropion hydrochloride), Ambien (zolpidem tartrate), and Lunesta (eszopiclone).

Perhaps not unlike a criminal who subconsciously wants to get caught, the Army left a bread crumb trail of clues for anyone bothering to sift through thousands of pages of evidence (which apparently excludes most, if not all, of the media).

Four footnotes in the section of the Army's report discussing Spc Ivan Lopez's Behavioral Health (BH) refer to Exhibits H-7 through H-10, describing the exhibits as FDA labels for drugs.

Exhibit H-7 is referred to as "FDA Label - Celexa."

Exhibit H-8 is referred to as "FDA Label -" followed by the first letter "W" or "V" with the remainder of the drug name redacted.  So now we know to keep an eye out for a second medication that starts with either a "W" or a "V".  Exhibits H-9 and H-10, respectively, are referred to as "FDA Label -" with the names of the medications completely redacted.

In Appendix 3, the Army painstakingly defined the plethora of terms used elsewhere in the report.  Among the definitions include descriptions of Ambien, Ambien CR, Bupropion, Celexa, Citalopram, Lunesta, Polypharmacy (ya think?), Wellbutrin, and Zolpidem.

The appearance of Celexa/Citalopram in the list of definitions is consistent with the footnote referring to Exhibit H-7 as "FDA Label - Celexa."  The appearance of Wellbutrin (bupropion) in the list of definitions is consistent with the footnote referring to H-8 as "FDA Label -" followed by a mostly redacted medication name starting with the letter "W" or "V".  Not surprisingly, there are only two other psychotropic medications, Ambien and Lunesta, appearing in the list of definitions, corresponding presumably to Exhibits H-9 and H-10, FDA drug labels for the two other unnamed drugs.

In addition to inadvertently divulging, despite significant black ink expended, how many and which psychotropic medications Spc Lopez was prescribed and taking (remember the toxicology results revealed the normal/expected, ie. not abnormal, presence of medications plural), the Army perhaps again unwittingly disclosed in Appendix 5 just how extensive Spc Lopez's mental health treatment actually was, and the myriad of Army mental health providers who examined and/or treated Spc Lopez.

Appendix 5 indicates that investigators reviewed "[m]edical records notes by the following providers constitut[ing] the majority of Specialist Lopez-Lopez's significant medical events," then lists a number of mental health providers at Fort Bliss, Fort Leonard Wood and Fort Hood, and footnotes the dates from medical records notes corresponding to when Spc Lopez met with each of the respective mental health providers.

Over a ten month period from June 14, 2013 to March 10, 2014, Spc Lopez appears to have met with a half dozen mental health providers on at least ten occasions, possibly meeting with two providers on the same date on two of those occasions.  Records show Spc Lopez met with a Social Worker therapist, four psychiatrists, and a nurse practitioner who refilled prescriptions. 

Army records indicate Spc Lopez visited an Embedded Behavioral Health (EBH) Social Worker therapist at Fort Bliss on June 14, 2013, July 31, 2013, October 2, 2013, and October 28, 2013; an EBH psychiatrist at Fort Bliss on June 20, 2013; an EBH psychiatrist at Fort Bliss on July 31, 2013, and August 27, 2013; an EBH psychiatrist at Fort Bliss on September 24, 2013, October 28, 2013, November 15, 2013, and November 19, 2013; a nurse practitioner at Fort Leonard Wood on 24 January 2014 to refill prescriptions; and a psychiatrist at Fort Hood on March 10, 2014 to evidently request more medication.  At the time of the shootings, Spc Lopez had a follow-up BH appointment scheduled for May 19, 2014.

During his last BH appointment on March 10, 2014, according to the Fort Hood psychiatrist interviewed as part of the investigation, Spc Lopez "requested [redacted] and [redacted]."  Predictably, the Army blacked out what medications Spc Lopez requested and was provided during this last visit only two weeks prior to his shooting rampage.

Army records demonstrate that Spc Lopez sought mental health care of his own accord, followed up with mental health treatment as prescribed (both on a scheduled and walk-in basis), and requested refills of prescribed medications. 

These facts run counter to the narrative oft posited by Pharma-funded politicians whereby mass shooting tragedies are preventable - if only the shooters had access to mental health care, cooperated with their treatment, and complied with prescribed medications. 

What also emerges from the Army's selective redaction of its report and appendices is that they were only concerned with redacting a certain type of PHI - Pharma Harmful Information, as opposed to Protected Health Information.  In Appendix Tab "E," for example, SPC Lopez's wife stated that he "had a physical profile which expired, but he still suffered from pain on his back and he would still have to conduct physical training per the chain of command's orders."

It says a lot about how invested the Army is in its close relationship with Big Pharma when it does not bother redacting references to Spc Lopez's physical injury and pain, but does everything in its power to conceal Spc Lopez's mental health diagnoses and prescribed medications.

The Army's findings, based on thousands of pages of evidence, are a stinging indictment of the failings of medicalized psychiatry in America, which could alternatively be referred to as chemical mood/behavior management.  The Army's conclusion that Spc Ivan Lopez received the best possible mental health care was emphatic: "After an independent review of the medical and behavioral health care and treatment provided to SPC Lopez-Lopez, no deviation from standard care occurred in any component of the medical treatment continuum."


In other words (ATTENTION TAXPAYERS): Psychiatry's standard of care cannot prevent mass shooting tragedies. 

If the determination of independent psychiatrists that no deviation from the standard of care occurred in the case of Spc Lopez is correct, then it must also follow logically that psychiatry's standard of care cannot prevent mass shooting tragedies. 

The fact that American psychiatry - with its almost singular reliance on chemical mood/behavior management - cannot prevent mass shootings has not prevented Rep. Tim Murphy (R-PA) and other Pharma-funded politicians from attempting to force American taxpayers to part with billions of dollars under just such a false promise.  With the pharmaceutical lobby now the largest by far in the U.S., spending over $230M last year to pitch their agenda to Congress, some have begun to question whether we're now living in the United States of Pharma. 

In addition to revealing the impotence of psychiatry and its chemical mood/behavior management to prevent mass shootings, the Army's report and appendices shed more light on who Ivan Lopez was as a person.

Spc Lopez's wife described her husband as "a calmed person who was always quiet and she was the one in the relationship who was outspoken... [She] stated that SPC Lopez-Lopez was not confrontational and when he was mad he just kept it to himself."  Spc Lopez's wife further stated that her husband "was not a violent person.  [She] stated in one occasion she punched him after an argument and he did not hit her.  She stated he was a calmed person."

A childhood friend who knew Ivan Lopez since the seventh grade told investigators that "he did not think Specialist Lopez-Lopez would do something like this.  He said on multiple occasions that Specialist Lopez-Lopez never joked about hurting himself or others... [He] did not see anything that would suggest Specialist Lopez-Lopez would take the actions he did."

When asked to describe Ivan Lopez, another person who knew him since he was fourteen years old described him as "Humble, honest, kind, good father, loving, for me he was like a son."

A Private at Fort Hood who was friends with Spc Lopez told investigators: "He was always a happy guy.  Every time I talked to him, he never had anything bad to say.  I never saw him angry and he never talked about violence."

A Sergeant who got to know Spc Lopez during a reclassification course at Fort Leonard Wood told investigators: "To me, nothing stood out about Spc Lopez that would make him a high risk Soldier.  I never saw him get mad or angry during our time together. Sometimes I would ask if everything was alright, but he never seemed angry.  He did not seem depressed."

According to people who lived and worked with him, Ivan Lopez was not an angry, violent, or depressed person, but rather a decent human being.

So what could compel an even-tempered individual to go on a deadly shooting rampage?

A peek inside Ivan Lopez's medicine cabinet tells the story...

Spc Lopez took bupropion hydrochloride, better known by its brand name Wellbutrin, which is prescribed for depression and off-label for smoking cessation.  The label for Wellbutrin contains a black-box warning of increased risk of suicidal thinking and suicidal behavior, lists agitation and hostility as being among the most common adverse reactions, and warns families and caregivers to immediately report emerging agitation or irritability to healthcare providers.

Bupropion hydrochloride, when prescribed for smoking cessation under the lesser-known brand name Zyban, also carries an FDA-mandated warning of homicidal ideation.

It was reported that former Assistant District Attorney Myron May was also prescribed a cocktail of psychotropic drugs including the antidepressant Wellbutrin prior to his mass shooting rampage on the campus of Florida State University on November 20, 2014.

Andrea Yates was also on a cocktail of psychotropic drugs including the antidepressant Wellbutrin when she drowned her five children -John, Paul, Luke, Mary, and Noah - on June 20, 2001.

Homicide has been reported to the FDA as a side-effect of Wellbutrin and bupropion hydrochloride seventeen times.

Likewise, the label for citalopram hydrobromide, better known by the brand name Celexa, which Spc Lopez was prescribed, carries a black-box warning of increased risk of suicidal thinking and suicidal behavior, agitation, aggressiveness, hostility and impulsivity.

Homicide has been reported to the FDA as a side-effect of Celexa and citalopram fifty-eight times.  There have also been forty-three reports to the FDA of homicide as a side-effect of its chemical cousin, escitalopram oxalate, better known as Lexapro.

Spc Lopez was also prescribed zolpidem tartrate, better known as Ambien, to treat insomnia.  The Ambien label states that "worsening of depression and suicidal thinking may occur."  According to the Ambien label, other reported side-effects include agitation, hallucination, abnormal thinking, and aggressiveness.

Homicide has been reported to the FDA as a side-effect of Ambien and zolpidem tartrate over one hundred times.

In addition to Ambien, Spc Lopez was also prescribed the sleep-aid eszopiclone, better known as Lunesta.  Like Ambien, the Lunesta label warns that "worsening of depression and suicidal thinking may occur."  The Lunesta label also contains the following chilling warning: "A variety of abnormal thinking and behavior changes have been reported to occur in association with the use of sedative/hypnotics.  Some of these changes may be characterized by decreased inhibition (e.g., aggressiveness and extroversion that seem out of character)... Other reported behavioral changes have included bizarre behavior, agitation, hallucinations, and depersonalization."

Homicide has been reported to the FDA as a side-effect of Lunesta and zopiclone five times.

Three of the four drugs prescribed to Spc Lopez (Celexa, Wellbutrin, Ambien) appear on a list of 31 drugs Harvard and Wake Forest doctors identified as being associated with an elevated risk of violence based on a study of FDA Adverse Event Reporting System (AERS) reports.

Each of the psychotropic drugs prescribed to and taken by Spc Lopez carry warnings of increased risk of suicidal behavior and suicidal thinking, depression, agitation, aggressiveness, irritability, hostility, etc.  If any one of the aforementioned psychotropic drugs could cause someone to act aggressively out of character and/or suicidally, one can only imagine what they could drive a person to do if taken concomitantly.

The fact of the matter is that we are left to our imagination as to the possible adverse effects of such reckless polypharmacy, because these psychotropic drugs have never been tested to see if they can be taken together safely.  What the Army is doing effectively amounts to experimentation on our soldiers.

From the Army's report and appendices, there is no doubt that Spc Lopez was on a multi-drug regimen qualifying as polypharmacy by their own definition.  The most conservative interpretation of the available data would be that Spc Lopez was on at least one antidepressant and one sleep medication at a time, and that the Army either prescribed a different antidepressant and a different sleep aid because the first ones prescribed were not achieving the desired results, or worse that the Army prescribes different drugs in the same class (e.g. antidepressants or sleep aids) interchangeably. 

In either of the above two scenarios, there would be a period of increased risk withdrawing from the old antidepressant and the old sleep aid while starting a new antidepressant and a new sleep aid, since both stopping and starting a psychotropic drug increases the patient's risk profile.  Of course, the increased risk is further multiplied with the stopping and starting of multiple psychotropic drugs.

Another nightmare scenario is that the Army doubled up on the antidepressants and/or sleep aids when they were not working by themselves.

Odds are that we will never know which of the above three scenarios produced the horrific tragedy that occurred at Fort Hood on April 2, 2014, due to the Army's lack of transparency.

What we do know for sure is that the Army's management of psychotropic polypharmacy is haphazard at best.  "After the shooting incident," wrote a psychiatrist and Program Director of the Center for Forensic Behavioral Sciences, "only two commanders recalled having ever seen a polypharmacy list of names.  The hospital is again short staffed on managing the polypharmacy project because the pharmacist in charge deployed."  

Classic.  A psychiatrist blaming polypharmacy mismanagement on a pharmacist.  Can pharmacists write prescriptions?  Don't think so. 

Our fighting men and women deserve better than a whitewash and psychiatric blame-shifting. 

Parents Against Pharmaceutical Abuse (PAPA) calls on the U.S. Army to release Exhibits Tab "H" of Appendix 4.

RIP: SFC Daniel M. Ferguson,
SSG Carlos A. Lazaney-Rodriguez, SGT Timothy W. Owens, SPC Ivan A. Lopez-Lopez


Parents who want alternatives to mental health drugs, suggested by teachers, mental health professionals, doctors or ex-spouses, may be relieved to know that there is a medical test that can be performed to evidence whether your child can even metabolize the drug that is being proposed.


This test has been around for a long while, yet the medical community has not used it nor made it broadly known as it may cut into pharma spending. The test is a genomic test, meaning it tests the DNA function and structure and through this, can determine if the individual can break down the drug and move it through the body or will the liver become overwhelmed and the individual become toxic, and therefore experience the adverse effects of the mental health drugs, such as psychosis, worsening depression, anxiety, mania, delusions, suicidal thoughts, homicidal thoughts and more.


Like all things in our culture and in our society that revolves around money, the test is currently being used and promoted for use to the psychiatric community.  Now, if the use of it were as healthful as what has been suggested above, in order to test the individual to see if they will be able to metabolize the drug, therefore they would most definitely be wise to learn of the alternative, non pharmaceutical treatment, then we would live in an ideal world. Yet, that is not the intention, nor the purpose for promoting this test to the psychiatric community.  Mental health professionals are using the test in order to find the drug that rates “best” in their estimation. (Please refer to the FDA warnings on mental health drugs to understand the risks they carry, Mental Health drugs cannot rate "best" in any estimation.


In a highly scientific article regarding this genomic testing, the facts relayed are as follows.  “drug-metabolizing enzyme genes, such as cytochrome P 4 5 0 2D6 gene (CYPD6), were identified.” That’s the good news.  The genes that partake in metabolizing drugs were identified through genomic research.


The article continues, with the benefit of this news as it “provides clinicians with the opportunity to identify both poor metabolizers and ultrarapid metabolizers…”


The article does point out that “In recent years, the potential iatrogenic harm (illness caused by the drug) associated with psychotropic medications has become increasingly obvious, with “black-box warnings” being attached to antidepressants, antipsychotic medications, stimulants, and mood stabilizers.”


Again, this is not necessarily new technology, this is new to the public, “The identification of specific gene variants associated with idiosyncratic responses is about 50 years old, and the recognition that some psychiatric patients metabolize antidepressants at dramatically different rates has been documented for several decades.”


Some information for those parents who want to approach their doctors to do this testing and assert their right to alternative treatment for their child:


“CYP2D6 was the first drug-metabolizing enzyme gene that was genotyped to identify psychiatric patients with increased or decreased metabolic capacity.  It is located on chromosome 22 and consists of 4382 nucloetides…


The CYP2DC enzyme plays a primary role in the metabolism of more than 70 substrate medications, including twelve psychotropic medications…


The most important CYP2D6 phenotype to identify is the poor 2D6 sustrate metabolizer phenotype. Patients who are poor metabolizers are at increased risk of adverse events when they are prescribed 2D^ substrate medications, because of their low metabolic capacity.”



For more factual information that helps to get you fully informed on your rights in the field of mental health, visit






Psychiatric pharmacogenomics testing in clinical practice,

Family law and parental rights has everything to do with attorneys and how they handle the case for their client.  If you are a parent who is either getting a divorce or already divorced, you know well that parental rights are determined largely by how your attorney services your needs or not.  Once mental health is introduced to the case, the game changes and parental rights may become obsolete.  In a presentation made to the Georgia Annual Bar Admissions Conference, in 2012, Dr. Michael J. Herkov, Neuropsychiatrist, spoke to the attorneys about mental illness. This may, on the surface, seem appropriate to some, but with further thought it seems absurd that an attorney would need to know about mental health. It is an admittance of our times, that mental health and the practice of, has entered into almost every single professional field in our culture. 

Teachers are given courses on mental health so that they can, supposedly, spot children who have learning disorders or behavioral issues and ensure that the student gets the “appropriate attention”.  Law enforcement officers are given courses on mental health so that they can, supposedly, prevent violence and disastrous situations in the community.  Again, on the surface, this may seem appropriate to some, and with further thought it’s actually practicing mental health without a license. 

In reviewing Dr. Herkov’s presentation, he is comparing the physician and the attorney and their value to society. In this comparison he mentions that attorneys “are sought out by the general public during times of personal vulnerability, turmoil, conflict, or stress.” He goes further to say that perhaps the attorney is more sought out than the medical professional during these times. That’s an incredible comparison and a clear path to now introduce the subject of mental health to the profession of law. 

In his own words, Dr. Herkov states, “the client is highly dependent upon the skill of the attorney in understanding and resolving the issue.”

With that in mind, consider the facts instead of the apparent, especially within the family court arena.  Factually, Dr. Allen Frances, former editor of the Diagnostic and Statistical Manual (DSM), “Adding to the woes of the medically ill could be one of the biggest problems caused by DSM 5. It will do this in two ways: 1) by encouraging a quick jump to the erroneous conclusion that someone's physical symptoms are 'all in the head'; and 2) by mislabeling as mental disorders what are really just the normal emotional reactions that people understandably have in response to a medical illness.” Factually, medical professionals have documented that there are medical tests that can be performed to identify physical illness or ailments that are causing mental health problems. Additionally, Dr. Frances is correct when he says that some of the symptoms can be “normal” reactions to life.  The New York Times published an article in 2011, titled, “For Some, Psychiatric Trouble May Start in Thyroid”, and the article reports, “In patients with depression, anxiety and other psychiatric problems, doctors often find abnormal blood levels of thyroid hormone. Treating the problem, they have found, can lead to improvements in mood, memory and cognition. Now researchers are exploring a somewhat controversial link between minor, or subclinical, thyroid problems and some patients’ psychiatric difficulties.” 

Returning to the imposed correlation between attorneys and mental health, Dr. Herkov, tells us, in his presentation at the Bar Admissions Conference, “Attorneys must possess basic cognitive, emotional, and behavioral skills. These attributes are often referred to as the ‘essential eligibility requirements’ for the practice of law. The importance of these qualities is well recognized by state boards of bar examiners (and/or their separate character and fitness committees) whose members are charged with verifying that applicants to the bare meet these basic criteria.”

So, not only are attorneys reviewed for their mental health fitness, they are now familiar with the subject of mental illness in dealing with their own practices and clients and that familiarity came from a close scrutiny of their own well-being by the Bar Examiners.  Hence, the double-edged sword; the attorney first reviewed as a potential mental health patient, and then the attorney as the quasi-mental health practitioner.  The standard of care has become mental health diagnosing and medicating.  After all, if an attorney is found to be mentally unfit, meds are prescribed and taken and then he or she is deemed fit. 

No wonder, by the time a parent takes their case into family court, they may feel that their case is already taken a wrong turn. As many parents know, there is a whole cast of characters assigned to divorcees, within the family court arena that are mental health professionals.  Whether that is the child custody evaluator, the parent-coordinator, the guardian ad Litem or the court appointed psychologists, you can add one more to that cast, and that is potentially, your own attorney.  Keep in mind that most attorneys will have had a crash-course in mental health prior to opening the doors to their office.  

When it comes to divorce issues, one issue that is plaguing family courts, is the issue of psychotropic drugging.  If one parent does not want their child to take mental health drugs and the other parent does want the child to take them, the cast of characters, mentioned above, will most assuredly be assigned to the case.  With that, there will be a most definite leaning in the direction of drugging the child. Consider, not only your choice of attorney, who may or may not be on the meds themselves, but also the court appointed professionals.  Dig deep and find out who is influencing the proceedings in your case. 

In a Tampa Bay Times article, the public got a glimpse of the type of psychologist who might work in the family court arena. “As a psychologist who works primarily in the family courts, Flens and others like him stand at an unusual crossroads between social science and the law. Those who occupy it have enormous influence over cases whose emotional stakes are among the judiciary's highest. Expert witnesses who testify about the best custody arrangement for a child can salvage or ruin a parent's life, and their opinions shape the upbringing of the kids involved. These fateful choices command a high price. Court-approved psychologists routinely bill themselves out at rates of hundreds of dollars per hour; a single evaluation can cost litigants $10,000 or more.”

Dr. Herkov’s presentation continues with a definition of mental illness, mental disorders and guidelines for how to determine if the graduate of law school should be able to “engage in the practice of law” or whether they need “further examination, treatment, or monitoring before allowing the individual” to practice law. He uses the definition of mental illness that was published in the fourth edition of the DSM and he uses mental disorders and their definitions from the same manual.  Remember well, that Dr. Frances, former editor of this same manual, is denouncing the credibility of these disorder in that he is adding credibility to the fact that mental health symptoms can be traced back to an underlying physical cause that when evidenced by medical test, can be cured. 

Attorneys and mental health only becomes one more piece of the gigantic, moneymaking, puzzle that is the Pharma-Mental Health industry. An attorney, raked over the coals, in examination by the bar examiners, may learn well, firsthand that mental health disorders leads to mental health drugs and if he or she is placed on them, the cash-register for Pharma-Mental Health only continues to ring.  Once the court-appointed professionals are added to a case, the parent can hear again the ringing of that cash register, at his expense and the expense of his child’s well being. 

Parental rights are a relative term and the only comfort that can be offered is information.  The more information the parent has, prior to any court situation, the more he or she will be able to try to sway the relativity of his or her rights in the right direction. offers information to parents so that they can prevent and/or maneuver through these issues. An experienced advocate is available, by phone, for anyone who needs personal attention and information. 


The Bar Examiner, Volume 82, Number 1, march 2013, Mental Illness and The Practice of Law,

Psychology Today: Mislabeling Medical Illness As Mental Disorder,

New York Times: For Some, Psychiatric Trouble May Start in Thyroid,

Tampa Bay Times Article: Powerful Valrico family court psychologist has a troubled past,

Testimony of Patti Johnson
Colorado State Board of Education member
2nd Congressional District
before the
U.S. House of Representatives
Subcommittee on Oversight and Investigations hearing entitled
"Behavioral Drugs in Schools: Questions and Concerns"

September 29, 2000

I have been a member of the Colorado State Board of Education for the last six years. One of my platforms when I ran for office was to empower parents in their right to direct the upbringing and education of their children.

Over the years I was contacted by a number of parents who had been pressured to put their children on various psychotropic drugs for a variety of so-called learning disorders, the most common of which was Attention Deficit Hyperactivity Disorder (ADHD). In some cases they were told their child would not be allowed to attend school if he did not begin taking psychotropic drugs.

One parent who was given the option of placing her son on a stimulant drug or removing him from school elected to home school her son. She told me that it just didn’t make sense that a straight A student would be labeled "learning disabled." A Douglas County parent I spoke with said she was told her son had ADHD. What she was being told about the behavior her son supposedly exhibited and what she observed were not consistent. She investigated the matter and the school’s special education director eventually admitted that she had coaxed the teacher to answer the questions of the checklist used to determine if the child had ADHD in a certain manner so her son "would get the help he needed." This infuriated her so badly she removed her son from the school.

A Jefferson County parent who contacted me said he at first complied with the school’s direction to have his son take a stimulant drug. The drug caused his son to become violent, he began taking steak knives out of the kitchen and stabbing his stuffed animals. When the parent took him off the drug, the principal of the school began pressuring him to resume the stimulant -- so much pressure that the matter is now in court and the father could forfeit parental rights if he disagrees with the decision of the court on whether or not to place his child on Ritalin. Many more examples exist.

When I investigated the issue I realized that the so-called psychiatric learning disorders are an effort to "medicalize" failures in instruction and discipline at the expense of the child’s well being and the rights of the parent. Some of the learning disorders listed in the American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders (DSM) illustrate this point.

For example, the fourth edition lists number "315.1, Mathematics Disorder." The diagnostic criteria for this is "Mathematical ability, as measured by individually administered standardized tests, is substantially below that expected given the person’s chronological age, measured intelligence, and age-appropriate education." Likewise, the diagnostic criteria for "315.2, Disorder of Written Expression" labels the child with this disorder if he scores low on written tests.

The label of ADHD is assigned if the child exhibits such symptoms as not listening when spoken to, is forgetful, fails to finish homework, fidgets, talks excessively, etc. -- the typical behavior of a normal child. Parents of children said to have these disorders are generally told that it is a neurological disorder or a chemical imbalance in the brain. Yet, at a Consensus Development Panel conducted by the National Institutes of Health on ADHD in November 1998, it was reported that "We do not have an independent, valid test for ADHD, and there are no data to indicate that ADHD is due to a brain malfunction. Further research to establish the validity of the disorder continues to be a problem. This is not unique to ADHD, but applies as well to most psychiatric disorders..."

Educators are not allowed by law to practice medicine. Yet, the adjudication a child has one of these "disorders" and should be placed on "medication" and into special education is often done by a team which includes the parent, a teacher, a social worker, a special education teacher and the principal. The above factors led me to introduce a resolution before the Colorado State Board of Education entitled "Promoting the use of academic solutions to resolve problems with behavior, attention and learning." It reminded educators that their role was to teach and urged them to refrain from advising parents on medical matters. This was passed by a vote of 6 to 1 by the Board in November 1999.

Unfortunately, financial incentives exist for schools to label children with learning disorders. Understanding these incentives requires a brief review of the laws that affect special education.

The legislation which is now the Individuals With Disabilities Education Act (IDEA) was originally the Education for all Handicapped Children Act of 1975. The intent of this legislation was to ensure that children with actual physical handicaps -- sight impairment, hearing loss, etc. -- were given the public education they are entitled to.

This law was reauthorized in 1990 and the name changed to the Individuals with Disabilities Education Act. There were few procedural changes but the term "handicapped" was changed to "disabilities." The following year a memo was issued by the US Dept. of Education Office of Special Education and Rehabilitative Services which stated a child could qualify for special education if he was determined to have ADHD.

At this time, the IDEA legislation provided schools with an additional $400 per year for each child in special education. There followed a dramatic spike in the amount of methylphenidate consumed in the US. According to the DEA, the production and use of methylphenidate increased almost 6 fold between 1990 and 1995.

In IDEA as passed in 1999, the impairment category of "emotional disturbance." is defined in part to say the child has "An inability to learn that can not be explained by intellectual, sensory, or health factors." There is no mention of the fact that this may be due to a failure to instruct properly.

In December 1999, the Los Angeles Times reported that tens of thousands of California’s special education students were placed there not because they have a serious mental or emotional handicap, but because they were never taught to read properly. Reid Lyon, head of the federal government’s research efforts into reading and writing told the Times, "It’s where children who weren’t taught well go in many cases."

The intent of the original law, the Education for all Handicapped Children Act of 1975, was to ensure those with physical disabilities received a free and appropriate public education. These children are now being shortchanged because such a large percentage of special education funds are being diverted to vague psychiatric diagnoses. In 1998, 51.1 percent of special education children were in the category of "specific learning disabilities." These are the psychiatric diagnoses such as Mathematics Disorder, Disorder of Written expression and ADHD. Other disability categories also include psychiatric diagnoses.

IDEA legislation also contains a "child find" provision which requires states to actively seek out any children who may qualify for special education in order to receive federal special education funds. The child find program starts at birth in Colorado. This, of course, serves to push up the numbers of children labeled with ADHD.

The so-called learning disorders have, sadly, become a way for financially strapped schools to make ends meet. In many states, schools have become authorized Medicaid providers and funds can be collected in behalf of a child labeled with one of the learning or behavior disorders. This can be such a lucrative cash cow that in a letter dated October 8, 1996, the Illinois State Board of Education strongly encouraged the superintendent of one of its districts to participate in Medicaid incentives. The letter stated that Illinois had received $72,500,000 in federal Medicaid money in 1996 and that Medicaid dollars have been used for a variety of non-medical purposes and that "the potential for the dollars is limitless."

To assist schools in identifying children to label with "learning disorders," a number of checklists are made available to schools through the ERIC (Educational Resource and Information Center) database, which is a federal clearing house for educational materials. Yet, despite the expense created by such actions, these children are not receiving the education they are entitled to. Though the standards set for special education children are often lower, their graduation rate in the 1995 -1996 year was only 28.9 percent!

To the degree educators are expected to diagnose children, they are being distracted from their main duty which is to provide our children a quality education. Our schools are the only institution entrusted to attend to the academic needs of our children and their mission must not be diluted. I urge this committee to do everything in its power to get schools out of the business of labeling children and back to the job of teaching.

Thank you.

Patti Johnson
Colorado State Board of Education
Second Congressional District

How Did an African-American Attorney End Up Riddled with Bullet Holes on the Steps of a Florida State University Library?  Why is His Legacy Now Being Perverted to Promote Psychotropic Drugs that Killed a Gifted Young Black Role-Model?

     When a twenty-five year-old white Colorado University graduate school dropout named James Holmes emerged from an Aurora, CO movie theater after killing twelve people and wounding seventy others, he was taken into custody without injury, and currently awaits trial for multiple murders.  When a thirty-one year-old black Florida State University and Texas Tech Law School alumnus and former prosecutor named Myron May emerged from a campus library in Tallahassee, FL after wounding three people, he was reportedly shot by police twelve times, his crumpled body bleeding out on the sidewalk.

     Though Mr. Holmes and Mr. May experienced vastly different fates at the hands of law enforcement, the two share something in common besides having embarked on shooting rampages – both men took psychotropic medications that the FDA warns can cause suicidal behavior, psychosis, hallucinations, mania, aggressive behavior and violence.

     While executing a search warrant on Mr. Holmes' residence, law enforcement discovered prescription bottles of sertraline (Zoloft) and clonazepam (Klonopin).  Sertraline is a Selective Serotonin Reuptake Inhibitor (SSRI) antidepressant that the FDA warns can increase the risk of suicidal thoughts and behavior in children, adolescents and adults under the age of twenty-five.  During FDA hearings held in 2004 on the safety of SSRIs, experts urged the FDA to issue a suicide warning for patients of all ages, but the FDA declined to do so, setting a disputed and what some believe arbitrary cut-off age of twenty-five for the SSRI suicide warning (Holmes was twenty-five at the time of his shooting rampage).  Clonazepam is a benzodiazepine used to treat panic attacks that the FDA warns also increases the risk of suicidal thoughts and behavior.

     Admitted to the Texas and New Mexico bars to practice law and a former Dona Ana county, NM prosecutor, Mr. May returned to Florida to study for the Florida bar exam, which he was reportedly planning to take in February 2015.  Like many college students in America cramming for exams and an increasing number of adults attempting to enhance their performance in the workplace, Mr. May may have sought after a so-called “study” drug, which can only be obtained legally with a prescription, to help him perform better at work and to assist in his exam preparation.  Mr. May was given the controversial diagnosis of Adult Attention Deficit Hyperactivity Disorder (ADHD), and was prescribed Vyvanse (lisdexamfetamine).  While consumers remain largely unaware of the dangers of these so-called “study” drugs, like their chemical cousin methamphetamine, methylphenidate (e.g. Ritalin, Concerta, Focalin, Methylin, etc.) and amphetamine-based (e.g. Adderall, Vyvanse, Dexedrine, etc.) psychostimulants have been known for years in the medical community to induce psychosis.  So much so that in 2006, the FDA Division of Drug Risk Evaluation (DDRE) recommended issuing a warning that any of the stimulant drugs used to treat ADHD, at regular doses, in patients with no risk indicators or prior history, can cause hallucinations (visual, audible, tactile), psychosis, mania, aggressive behavior and violence.  Based on a review of adverse event reports to the FDA and a meta-analysis of clinical trial data, an expert testified to the FDA Pediatric Advisory Committee in March 2006 that 2 to 5 out of every 100 patients taking stimulants experience psychotic adverse effects.  

     After taking Vyvanse, Mr. May reported to law enforcement in New Mexico that he heard voices coming from the walls in his residence, and that he believed that he was being targeted or otherwise under surveillance by the government.  Mr. May also experienced insomnia -- a common adverse effect of psychostimulants that can increase the risk of psychosis -- reportedly staying up for four to five days.  While paranoid psychosis is a familiar adverse effect of the stimulant drug Mr. May was taking, his experience as a profiled young black man in America may have exacerbated the paranoia he experienced on the drug.  In a Facebook post, Mr. May described three out of ten DWB (Driving While Black) profiling incidents that he indicated having experienced.  With the paranoia Mr. May experienced from Vyvanse, his interpersonal relationships unraveled, and he brokeup with his girlfriend.  In a Las Cruces police report describing an encounter with his former girlfriend during which he handed her a piece of what he believed to be a surveillance device for safekeeping, she described him as acting strangely after having been diagnosed with ADHD and taking medication for the disorder.

     On top of his amphetamine-induced psychosis, Mr. May likely felt sadness as the result of the loss of an intimate relationship.  Like an increasing number of people who start out taking a single stimulant drug for ADHD, Mr. May quickly found himself also on the antidepressant Wellbutrin (bupropion), an SSRI that the FDA warns can increase the risk of suicidal thoughts and behavior, as well as the antipsychotic Seroquel to counter-act the paranoia arising from taking Vyvanse.  While doctors and psychiatrists around the country are increasingly prescribing multiple psychotropic drugs concominantly, none of these potentially dangerous drug cocktails has ever been tested to determine whether the drugs can be safely taken together.

     Adding to the controversy surrounding the psychotropic drugs Mr. May was prescribed, according to one media account he was prescribed Vyvanse and Wellbutrin by a psychologist, not a medical doctor or psychiatrist.  New Mexico is one of only two states including Louisiana where it is legal for psychologists to prescribe medication.  Since the passage of Louisiana's law allowing psychologists to prescribe medication, that state now has one of the highest rates of ADHD diagnosis and medication in the nation.  The problem has reached such epic proportions that Kathy Kliebert, LA Department of Health and Hospitals Secretary, has held public hearings on the issue. 
     Whereas the media has branded Mr. May as having suffered from a severe mental disorder, there is no indication in any media reports of him having any psychiatric problems prior to seeking help for distractibility at work, or prior to taking psychosis-inducing amphetamines.
     Like Mr. May, 34 year old Aaron Alexis was another successful young black man, achieving the rank of petty officer third class in the Navy and obtaining a secret security clearance.  Working as a subcontractor for Hewlett-Packard Enterprise Services, Mr. Alexis provided support for the Navy Marine Corps computer network.  Mr. Alexis reportedly expressed frustration to a former roommate that he had not been adequately paid for the work he performed.  Also like Mr. May, Mr. Alexis was taking an antidepressant (Trazodone) that the FDA warns increases the risk of suicidal thoughts and behavior.  Also like Mr. May, Mr. Alexis embarked on a shooting rampage, killing twelve people at the Naval Shipyard in Washington, D.C.  Two weeks prior to the attack, Mr. Alexis visited the emergency room at the V.A. in D.C. complaining of insomnia, where he was dispensed more Trazodone.  Like Mr. May, Mr. Alexis was also shot and killed by first responders.


     Despite FDA warnings of psychosis, suicidal thoughts and suicidal behavior associated with the medications that Messrs. May and Alexis were taking at the time of their otherwise uncharacteristic acts of violence, and rather than investigate a possible causal link between the psychotropic drugs and mass shootings, Pennsylvania Republican Congressman Tim Murphy, a thirty-year psychologist and major recipient of pharmaceutical and mental health industry donations, has sought to exploit Messrs. May and Alexis in support of his bill, the Helping Families in Mental Health Crisis Act (HR 3717), which would not only involuntarily commit and medicate adults, criminals, and veterans; but also in some cases infants, toddlers, children, and adolescents without parental consent. 

     Considered by many to be a boondoggle for Rep. Murphy's pharmaceutical company patrons, the bill would provide millions in funding to diagnose infants and toddlers as young as one or two years old using the subjective, unscientific Ages and Stages Questionnaire (ASQ); would allow minors to be evaluated, diagnosed and medicated with psychotropic drugs without parental consent; would transform the nation's prison population into a captive market for pharmaceutical companies subjected to forcible psychotropic drugging; would drug more veterans to death like Sean Gonzalez who died at Central Florida Behavioral Hospital after being administered psychotropic drugs; would fund mental health police similar to those in Midland, TX who shot and killed Rosendo Gino Rodriguez after he refused to take his medication.

     Like Messrs. May and Alexis, Messrs. Gonzalez and Rodriguez were also minorities killed by the largely white mental health industry, which once labeled the desire to escape slavery as a mental disorder called Drapetomania.  In a perverse, yet genius twist of reverse psychology, the same mental health establishment that once pathologized a black person's desire for freedom is marketing to the African-American community the notion that discrimination has deprived black children the opportunity to be diagnosed and medicated for mental disorders like ADHD on a par with white kids.  A fact check dispels the mental health racial inequality hype: 9.5% of black children are diagnosed with ADHD versus 9.8% of white children.  The cynical, yet cunning psychotropic marketing strategy has fueled new growth: a recent study revealed that poor children have experienced a 59% increase in ADHD diagnoses versus only a 10% increase for middle and upper income children.  In search of ever-expanding markets and profits, the pharmaceutical industry is stepping up efforts to fully exploit minority communities, which represent an economically important demographic to their bottom line.

      Unfortunately, talented and successful minorities are falling victim to slick Madison avenue messaging that there is a pill to cure all ills, their once promising lives cut short along with others.

     As more details of their psychiatric treatment and psychotropic drugging have come to light, Rep. Murphy's initial characterization of Messrs. May and Alexis as poster children for a supposed lack of access to mental healthcare in this country has taken a subtle twist.  Previously referring to mass shooters as “untreated,” Rep. Murphy has nuanced his remarks to reflect emerging indications that most mass shooters in recent history received more mental health treatment than the average American (e.g. Myron May, Aaron Alexis, Adam Lanza, Elliot Rodger, Ivan Lopez, etc.), now labeling these individuals instead as “under-treated.”

     Even as Murphy's bill promotes so-called Evidenced-Based Treatment (EBT), controversial due to the “evidence” being largely derived from studies primarily funded by the pharmaceutical industry, Rep. Murphy has ignored increasing evidence of a temporal, if not causal link between psychotropic drugs and high profile mass murders in America.  Ironically, under HR 3717, dead mass shooters benefit from more privacy protection than living mental health patients, whose HIPAA privacy rights the bill seeks to erode, indiscriminately granting “caregivers” access to mental health providers and records in order to ensure patients maintain medication compliance.  With the foundational psychotherapy tenet of confidentiality thrown out the window, EBT has become synonymous in HR 3717 with psychotropic drugging, suiting Rep. Murphy's pharmaceutical donors well, along with so-called “advocacy” groups funded by the pharmaceutical industry like the National Alliance on Mental Illness (NAMI), Children and Adults with Attention Deficit/Hyperactivity Disorder (CHADD), and Autism Speaks.  

     Under HR 3717, the decision of whether or not to release mental health records would rest entirely upon the unenforceable ethics codes of psychologists, psychiatrists and physicians – which do not carry the force of law – rather than in the hands of the patient, as has long been the case.  Citing a controversial concept known as anosognosia, schizophrenic or bipolar patients' purported incapacity to comprehend their mental disorder or need for treatment, Rep. Murphy has attacked a long-standing common law principle that people must pose a danger to themselves or others before they can be involuntarily committed or have their mental health records involuntarily released, deriding the legal definition as being two-hundred years old.       

     Dismissing the two-century old notion of liberty as being unenlightened by the marvels of modern psychocraft as embodied in the DSM 5.0, psychiatry's voted-on, yet scientifically unmeasurable "Bible" of mental disorders, Rep. Murphy has on the other hand sought vigorously to protect the civil liberties of dead mass shooters.  On the second anniversary of the Newtown massacre, it stands as a mark of shame that during congressional hearings following the tragedy, the subject of Adam Lanza's psychotropic medication history was strictly off-limits.  In fact, an attorney for the Connecticut Office of the Chief Medical Examiner successfully argued before that state's Freedom of Information Commission to keep Mr. Lanza's mental health records sealed from the public.  Attorney Patrick Kwanashie warned in his arguments to the commission that releasing Mr. Lanza's mental health records would be “harmful, because then you can cause a lot of people, um, to stop taking their medications, stop cooperating with their treating physicians, just because of the heinousness of what Adam Lanza did.”

     NRA-endorsed for his strong stance against gun control, Rep. Murphy has stated with great dramatic effect that we should be more concerned about what was in the mind of mass shooters than what was in their hand, but he has been notably silent about what was in their body.

     Rep. Murphy wants us to implicitly trust our civil liberties to the care of his profession, despite the fact that psychiatry failed to identify a homicidal maniac within its own ranks, namely Dr. Nidal Malik Hasan, the psychiatrist notoriously known as the first Fort Hood shooter; and was treating the second Fort Hood shooter, Spc. Ivan Lopez, with suicide-inducing SSRIs at the time of his more recent rampage.  Interviewed on CNN shortly after the second Fort Hood shooting in April of this year, Dr. Murphy outlined the post-mortem process: “We look at the kind of medications they were on.  Was it right?  Was it effective?”  The psychologist-cum-legislator further advised, “You also do a risk assessment to understand if that person on certain medications can increase the risk for some problems. They have to be closely monitored.”  What's that? Certain medications can increase the risk for some "problems?"  Which medications?  What kind of problems?

     Whereas HR 3717 calls out the controversial Ages and Stages Questionnaire (ASQ) by name and funds its expanded use, which many see as a license to diagnose and drug infants and toddlers, noticeably absent from Murphy's bill is any mention of a medication risk assessment, either by name or otherwise, which he himself recommended on national television.  There is absolutely no mention in the bill of the medications that, if we are to believe Dr. Murphy's comments, may not be “right” or “effective.”  Rather, his bill codifies protected class status for all antidepressant and antipsychotic medications.

     Even though mental health professionals are manifestly incapable of detecting or preventing the next mass shooter, perhaps we should be comforted by psychiatry's unrivaled ability to diagnose a ham sandwich.  In a famous study, a psychology graduate student, three psychologists, a pediatrician, a psychiatrist, a painter and a housewife posed as mental patients.  Of the twelve times the sane impostors were admitted into mental hospitals, eleven times they were diagnosed with schizophrenia, and once with manic-depressive psychosis.  Under HR 3717, mental health professionals will without a doubt wrongly diagnose people with schizophrenia, involuntarily commit them, and forcibly medicate them.  Only there won't be an attorney standing by with a writ of habeas corpus like in the aforementioned study.

    Last year, 171,744 involuntary exams were initiated under Florida's Baker Act.  That's an average of 471 per day.  Let that number sink in a bit.  Throughout Florida, stories of wrongful and abusive commitments surface everyday.  Consider the case of former psychologist Holli Bodner, who as part of a neighborhood dispute, filed a petition to have her neighborhood foe involuntarily examined, pursuant to the Baker Act, for such offenses as "working under the table" and "swearing."  Dr. Bodner was finally forced to surrender her license years later after attempting suicide, shoplifting at Macy's, smuggling oxycodone into a Sarasota County jail in her bra for an inmate, etc.  Equally troubling is the case of David Bush, a 61 year old African-American man who was involuntarily committed by Jacksonville Sheriff's Deputies last year and later found dead while in custody at UF Health Jacksonville.



     The only thing scarier than the growing trend of mental health police forces popping up across the country is that often times the involuntary detention for examination is outsourced to private security firms with even less oversight than law enforcement agencies.  In the case of Mr. Bush, his supervision was entrusted into the hands of rent-a-cop outfit G4S.  JSO determined that Mr. Bush somehow managed to hang himself -- while subdued in a 4-point restraint.  Case closed.

     When Hispanic Gulf War veteran Sean Gonzalez was involuntarily committed and detained for psychiatric observation earlier this year at Central Florida Behavioral Hospital, he was forcibly administered psychotropic medications and later found dead.




    In the case of Rosendo Gino Rodriguez, a 49 year-old Hispanic man in west Texas, his family called police to inform them that Mr. Rodriguez was not taking his medication.  These are the so-called "caregivers" to whom HR 3717 seeks to release protected mental health records, precisely to ensure that subjects maintain medication compliance.  According to the Midland, TX police department, "Midland County mental health officials were conducting a welfare check on Rodriguez" earlier this month.  Elsewhere in the official account, the "mental health officials" are alternately referred to as "deputies."  When mental health officials aka law enforcement confronted Mr. Rodriguez for not taking his medication, he locked himself in the bathroom.  A SWAT team busted down the door and shot him dead.  The incident is currently under investigation by Texas Rangers.     


     Under HR 3717, there will surely be many more abuses.

     Lulled into complacency by the pharmaceutical and mental health industry's carefully crafted narrative exploiting mass shooting tragedies while skillfully side-stepping any responsibility, the media have largely abandoned its professional curiosity in favor of printing Rep. Murphy's words directly or endorsing them in Op-Ed pages across the state and the country.

     Meanwhile, the Strengthening Mental Health in Our Communities Act (HR 4574), Arizona Congressman Ron Barber's Democratic alternative to Rep. Murphy's pro-Pharma Republican bill, has gained scant media attention.  Since the Democratic Congressman's bill seeks to strengthen and further invest in the Substance Abuse and Mental Health Services Administration (SAMHSA) and its recovery programs rather than gut them as Murphy's bill would do in the name of EBT, it does not benefit from the support of the pharmaceutical lobby or its “grassroots” marketing machine, otherwise known as “advocacy” groups.  Perhaps that's why we don't hear about Barber's bill in the news as much as Murphy's.        

Big Pharma Marketing Machine/Politicians Pocketing Pharma Money Creating Faux Mental Health Crisis to Boost Rx Drug Sales

Fact-Checking Rep. Tim Murphy's Talking Points:

Claim: The mental health crisis has turned our jails into the new mental asylums.  Mentally ill are disproportionately represented in prison populations, overburdening our prisons and jails.  

Fact: "This year, 10 county jails surveyed by I-News reported that, on average in 2013, 18 percent of their inmates were mentally ill."

Fact: "Every year, about 42.5 million American adults (or 18.2 percent of the total adult population of the United States) suffers from some mental illness, enduring conditions such as depression, bipolar disorder or schizophrenia, statistics released Friday reveal."

Fact: "FBI: Violent crime drops, reaches 1970s level.  U.S. violent crimes including murders fell 4.4 percent in 2013 to their lowest number since the 1970s, continuing a decades-long downturn, the FBI said on Monday."

Claim:  The mental health crisis has led to an increase in suicides.  If we do not reform the mental health system, the suicide epidemic will continue to grow out of control.

Fact:  The suicide rate in the U.S. is the same as it was thirty years ago, 12.5 per 100,000 in 2012 versus 12.4 per 100,000 in 1982.

Claim:  The mental health crisis has led to an increase in homelessness.

Fact:  "Despite a housing crisis, a great recession, rising income inequality, and elevated poverty, there is some good news among the most vulnerable segment of American society. America’s homeless population – an estimated 633,000 people – has declined in the last decade."

Antiepileptic Drugs (AEDs) | Mood Stabilizers affected by FDA warning of increased suicide risk:

Carbatrol (carbamazepine), Celontin (mesuximide), Depakene (valproic acid), Depakote (valproic acid), Dilantin (phenytoin), Equetro carbamazepine), Felbatol (felbamate), Gabitril (tiagabine), Keppra (levetiracetam), Klonopin (clonazepam), Lamictal (lamotrigine), Lyrica (pregabalin), Mysoline (primidone), Neurontin (gabapentin), Peganone (ethotoin), Stavzor (valproic acid), Tegretol (carbamazepine), Topamax (topiramate), Tranxene (clorazepate), Tridione (trimethadion), Trileptal (oxcarbazepine), Zarontin (ethosuximide), Zonegran (zonisamide)

FDA Statistical Review and Evaluation: Antiepileptic Drugs and Suicidality

Remember when others hijack your family, their misdeeds do not define you.  What defines you is what you do when it counts.  Jeremy Glick, a former national judo champion, was on United Flight 93 to fulfill his divine purpose.  His life was in preparation for that moment.  His selfless actions saved countless others.  So instead of sinking into self-pity over the hand you've been dealt, be grateful for the opportunity to bring your family's hijackers down before they can hurt countless others.  Every second counts.  What are you going to do with your time?  What are you going to do to help other children and families whose lives have been hijacked by pharmaceutical company greed, mental health industry chicanery, and institutionalized chemical restraint in public schools, child welfare services, and family/dependency courts?  What special skills do you bring to the struggle that can benefit others?  Dig deep, and do your part.  This is your time.

Jeremy Glick: American Hero

On September 11, 2001, Jeremy Logan Glick, 31, reluctantly left his Hewitt, New Jersey home on business as a sales manager with Vividence, Inc., a Web management company. He relished every moment he had with his three-month old daughter, Emerson, and wife, Lyz. One of six siblings raised in Oradell, New Jersey, Jeremy graduated from the University of Rochester and married his high school sweetheart. When confronted with the hijack situation on Flight 93, Glick phoned his wife. She recalls him calmly describing the terrorists and their threats. Glick, a former national collegiate judo champion and black belt, spoke to Lyz of plans being made by the passengers and crew to rush the terrorists. As their call ended, Glick told his wife he loved her and needed her to be happy.
Myths # 1-7: ADHD Drugs Improve Academic Performance (1) and Social Relationships (2); Reduce Depression (3), Substance Abuse (4), and Driving Accidents (5); and Promote More Stability in Employment (6) and Extra-Curricular Activities (7)

Mallinckrodt Methylin patient brochure: "Without diagnosis and proper management, ADHD can have devastating consequences, including failure in school, depression, violent behavior, substance abuse, relationship problems, and failure to keep a job."

FDA Response: "While the presentation excerpted above does not directly assert that Methylin will correct the problems of untreated ADHD, it is nevertheless misleading because it implies, in the context of the piece as a whole, that Methylin may reduce the likelihood or severity of the consequences of untreated ADHD listed above (i.e., poor academic performance, poor social-emotional development, violent behavior, substance abuse, and employment problems) when this has not been demonstrated by substantial evidence or substantial clinical experience. While Methylin is approved for the treatment of attention deficit disorders based on a demonstration of bioequivalence with the reference listed drug (RitalinCI (methylphenidate hydrochloride)), we are not aware of substantial evidence or substantial clinical experience demonstrating a positive effect of treatment with Methylin (or of treatment with the reference listed drug) on the outcomes listed above (i.e., academic performance, depression, violent behavior, substance abuse, and stable employment). If you have such data, please submit them to FDA for review."

Novartis Focalin XR web page: "Children and adolescents with Attention Deficit Hyperactivity Disorder (ADHD), if untreated, are at risk for poor academic performance. Teen pregnancy, problems with peers, car accidents, and physical injuries occur at a higher rate. Untreated, children and teens with ADHD are also at risk of conduct disorders, delinquency, and drug or alcohol abuse. Typically, adults with untreated ADHD experience academic hardships. These often start in childhood and are likely to worsen during college years. Untreated adults take longer to complete learning degrees. They are likely to have lower economic status, lower rates of employment, and more work-related problems. Untreated adults also have more problems in their relationships, more driving accidents, and more addiction—from alcohol to gambling. Living with ADHD doesn't have to be this way. People with ADHD have treatment choices. The results of untreated ADHD are serious and should not be ignored. There is no cure for ADHD. Proper treatment can help control symptoms, helping to reduce these risks."

FDA Response: "While these presentations do not directly assert that Focalin XR will correct the problems of untreated ADHD or lead to the hoped for outcomes, they are misleading nonetheless because the only sensible interpretation of placing the consequences of untreated ADHD in pieces promoting the use of Focalin XR for ADHD is to imply that Focalin XR may reduce the likelihood or severity of the consequences of untreated ADHD listed above (i.e., poor social–emotional development and job success, poor academic performance, impaired driving, smoking and substance abuse) and induce the desired treatment outcomes when this has not been demonstrated by substantial evidence or substantial clinical experience... While Focalin XR is indicated for the treatment of ADHD, FDA is not aware of substantial evidence or substantial clinical experience demonstrating that Focalin XR can help patients avoid these consequences."

Johnson & Johnson Concerta professional convention panel: "CONCERTA® helps children improve academic performance throughout the day."

FDA Response: "This presentation is misleading because it implies that use of Concerta will lead to an improvement in academic performance throughout the day when this has not been shown by substantial evidence or substantial clinical experience."

Johnson & Johnson Concerta web page: "Adolescence is a time of greater independence and responsibility. For most teens, the after-school hours are filled with plenty of activities, including: sports, clubs, part-time jobs, socializing with friends, household chores, and, of course, homework. ADHD can have an impact on all of these activities, so you want to be sure your teen's medication is doing its job. CONCERTA® provides consistent symptom management throughout the day, for up to 12 hours, helping your teen focus and manage behavior. This may benefit your teen's ability to socialize with family and friends, and pursue interests and hobbies outside of school. You also won’t have to worry about whether your teen needs another dose of medication, because a single dose in the morning is all it takes. As a parent, you naturally want your teen to do well in all areas of his or her daily life. With once-daily CONCERTA®, you can be confident that symptoms are being managed no matter what he or she is doing."

FDA Response: "This presentation is misleading because it asserts improvement with Concerta in a broad array of adolescent after school activities, such as athletics, clubs, and performance in part-time jobs, when this has not been demonstrated by substantial evidence. While Concerta has been shown to improve total scores on the Attention Deficit Hyperactivity Disorder Rating Scale (ADHD-RS), which measures ADHD symptoms such as fidgeting, not listening, and talking excessively, what has not been shown is that this improvement in ADHD-RS total scores is correlated with a positive effect on adolescents’ ability to pursue interests and hobbies outside of school and to do 'well in all areas of [their] daily life.'"

Myth # 8: People Treated With ADHD Drugs Are Less Likely To Commit Suicide

BMJ study: "At the population level, drug treatment of ADHD was associated with an increased rate of suicide related events (hazard ratio 1.31, 95% confidence interval 1.19 to 1.44)."

Myth # 9: ADHD is genetic, or neurobiologic, or caused by a chemical imbalance in the brain.

WHO study: "An average of 50% of children with ADHD (range: 32.8%–84.1% across countries) continued to meet DSM-IV criteria for ADHD as adults."

If ADHD is genetic, neurobiological or due to a hard-wired chemical imbalance in the brain, then why do half of children diagnosed with ADHD outgrow it by the time they reach adulthood? Can you outgrow Down syndrome? Cerebral Palsy?

Myth # 10: Only ADHD Drugs Reduce ADHD Symptoms.

Journal of Developmental and Behavioral Pediatrics
study: "One meta-analytic review of the effects of stimulant medication on ADHD children found an average effect size of 0.32 for response to administration of a placebo, indicating that there was approximately 30% improvement in children with ADHD who were given a placebo compared with children with ADHD who were given nothing, although results across studies were highly variable. Several other independently conducted reviews of stimulant medication for children with ADHD also report that the average rate of positive response to placebos ranges from about 20% to 30%."

What? A sugar pill will improve ADHD symptoms by 30%? Without the dangerous side effects?

How can that be?  The study goes on to explain...

"Evidence suggests that parents and teachers tend to evaluate children with ADHD more positively when they believe the child has been administered stimulant medication and they tend to attribute positive changes to medication even when medication has not actually been administered."

The study reveals the fatal flaw with diagnosing ADHD in the first place and when measuring the effects of stimulant medication on ADHD symptoms, namely that it's all in the eye of the beholder, ie. subjective... 

"The fact that subjective measures are the most widely used measures of treatment response in children with ADHD argues for the need to better understand how medication expectancies influence these measures and argues for the need to design trials that can accurately assess the direct pharmacologic effects separately from placebo effects."

NIMH 3-year follow-up study and 8-year follow-up study find that ADHD medication is no more effective than non-medication therapy.

Pages: « 1 2 3 »